A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model
View ORCID ProfileMacarius M. Donneyong, Yuxi Zhu, Teng-Jen Chang, Pengyue Zhang, Yiting Li, Katherine M. Hunold, ChienWei Chiang, Kathleen Unroe, Jeffrey M. Caterino, Lang Li
doi: https://doi.org/10.1101/2021.05.13.21252626
Macarius M. Donneyong
1Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH
2Division of Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus, OH
Yuxi Zhu
3Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH
Teng-Jen Chang
1Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, OH
Pengyue Zhang
4Department of Biostatistics, School of Medicine, Indiana University, Indianapolis, IN
Yiting Li
2Division of Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus, OH
Katherine M. Hunold
5Department of Emergency Medicine, College of Medicine, The Ohio State University, Columbus, OH
ChienWei Chiang
6Division of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH
Kathleen Unroe
7Indiana University School of Medicine, Indianapolis, IN
Jeffrey M. Caterino
5Department of Emergency Medicine, College of Medicine, The Ohio State University, Columbus, OH
Lang Li
6Division of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH
Article usage
Posted May 19, 2021.
A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model
Macarius M. Donneyong, Yuxi Zhu, Teng-Jen Chang, Pengyue Zhang, Yiting Li, Katherine M. Hunold, ChienWei Chiang, Kathleen Unroe, Jeffrey M. Caterino, Lang Li
medRxiv 2021.05.13.21252626; doi: https://doi.org/10.1101/2021.05.13.21252626
A comprehensive assessment of statin discontinuation among patients who concurrently initiate statins and CYP3A4-inhibitor drugs; a multistate transition model
Macarius M. Donneyong, Yuxi Zhu, Teng-Jen Chang, Pengyue Zhang, Yiting Li, Katherine M. Hunold, ChienWei Chiang, Kathleen Unroe, Jeffrey M. Caterino, Lang Li
medRxiv 2021.05.13.21252626; doi: https://doi.org/10.1101/2021.05.13.21252626
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2296)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11621)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3625)
- Geriatric Medicine (340)
- Health Economics (622)
- Health Informatics (2330)
- Health Policy (918)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (393)
- Neurology (3389)
- Nursing (193)
- Nutrition (512)
- Oncology (1776)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1012)
- Primary Care Research (409)
- Public and Global Health (6020)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)